MXPA02011517A - Uso de vectores de baculovirus en terapia genetica. - Google Patents
Uso de vectores de baculovirus en terapia genetica.Info
- Publication number
- MXPA02011517A MXPA02011517A MXPA02011517A MXPA02011517A MXPA02011517A MX PA02011517 A MXPA02011517 A MX PA02011517A MX PA02011517 A MXPA02011517 A MX PA02011517A MX PA02011517 A MXPA02011517 A MX PA02011517A MX PA02011517 A MXPA02011517 A MX PA02011517A
- Authority
- MX
- Mexico
- Prior art keywords
- gene therapy
- baculovirus vectors
- baculovirus
- vectors
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0012997.3A GB0012997D0 (en) | 2000-05-26 | 2000-05-26 | Gene delivery |
PCT/GB2001/002383 WO2001090390A1 (en) | 2000-05-26 | 2001-05-29 | Use of baculovirus vectors in gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011517A true MXPA02011517A (es) | 2004-01-26 |
Family
ID=9892534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011517A MXPA02011517A (es) | 2000-05-26 | 2001-05-29 | Uso de vectores de baculovirus en terapia genetica. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1283894A1 (ja) |
JP (1) | JP2003533992A (ja) |
KR (1) | KR20030072213A (ja) |
CN (1) | CN1430675A (ja) |
AU (1) | AU2001258657A1 (ja) |
CA (1) | CA2413326A1 (ja) |
GB (1) | GB0012997D0 (ja) |
HU (1) | HUP0302119A3 (ja) |
IL (1) | IL153070A0 (ja) |
MX (1) | MXPA02011517A (ja) |
NO (1) | NO20025657D0 (ja) |
PL (1) | PL360280A1 (ja) |
WO (1) | WO2001090390A1 (ja) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1392837A2 (en) * | 2001-05-29 | 2004-03-03 | Ark Therapeutics Limited | Gene delivery via a baculovirus vector |
AU2005319099B2 (en) | 2004-02-02 | 2010-09-16 | Ambrx, Inc. | Modified human growth hormone |
GB2429207A (en) | 2004-02-02 | 2007-02-21 | Ambrx Inc | Modified human interferon polypeptides and their uses |
KR101699142B1 (ko) | 2004-06-18 | 2017-01-23 | 암브룩스, 인코포레이티드 | 신규 항원-결합 폴리펩티드 및 이의 용도 |
DK1828224T3 (en) | 2004-12-22 | 2016-07-18 | Ambrx Inc | Compositions containing, methods including, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES |
EP1836298B1 (en) | 2004-12-22 | 2012-01-18 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
US8080391B2 (en) | 2004-12-22 | 2011-12-20 | Ambrx, Inc. | Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer |
US7816320B2 (en) | 2004-12-22 | 2010-10-19 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 |
ATE529442T1 (de) | 2005-06-03 | 2011-11-15 | Ambrx Inc | Verbesserte humane interferon-moleküle und ihre verwendungen |
PT2339014E (pt) | 2005-11-16 | 2015-10-13 | Ambrx Inc | Métodos e composições compreendendo aminoácidos não-naturais |
DK2615108T3 (en) | 2006-09-08 | 2017-01-30 | Ambrx Inc | Modified human plasma polypeptide or fc scaffolds and their applications |
WO2008030614A2 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Suppressor trna transcription in vertebrate cells |
KR20140012199A (ko) | 2007-03-30 | 2014-01-29 | 암브룩스, 인코포레이티드 | 변형된 fgf-21 폴리펩티드 및 그 용도 |
CN103965347B (zh) | 2007-05-02 | 2017-07-18 | Ambrx公司 | 经修饰干扰素β多肽和其用途 |
AU2008326324B9 (en) | 2007-11-20 | 2012-11-15 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
EP3103880A1 (en) | 2008-02-08 | 2016-12-14 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
UA118536C2 (uk) | 2008-07-23 | 2019-02-11 | Амбркс, Інк. | Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування |
CN101358204B (zh) * | 2008-08-29 | 2011-05-18 | 浙江理工大学 | 一种重组杆状病毒感染后细胞膜及细胞器膜蛋白的制备方法 |
EP3216800A1 (en) | 2008-09-26 | 2017-09-13 | Ambrx, Inc. | Modified animal erythropoietin polypeptides and their uses |
MX348657B (es) | 2008-09-26 | 2017-06-21 | Ambrx Inc | Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales. |
NZ600363A (en) | 2009-12-21 | 2014-07-25 | Ambrx Inc | Modified porcine somatotropin polypeptides and their uses |
CN102753573A (zh) | 2009-12-21 | 2012-10-24 | Ambrx公司 | 经过修饰的牛促生长素多肽和其用途 |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
BR112013003522B1 (pt) | 2010-08-17 | 2021-05-25 | Ambrx, Inc. | polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
KR20240024362A (ko) | 2014-10-24 | 2024-02-23 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 fgf-21 폴리펩티드 및 그의 용도 |
CN110637027A (zh) | 2017-02-08 | 2019-12-31 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
CN114736929B (zh) * | 2022-05-16 | 2023-06-09 | 睿征医药科技(武汉)有限公司 | 一种用于昆虫细胞中产生重组杆状病毒的组合物、方法及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100695590B1 (ko) * | 1996-11-01 | 2007-03-14 | 아크 테라퓨틱스 리미티드 | 산화질소 또는 프로스타시클린 생산을 자극하는 약제의 치료학적 용도 및 전달 기구 |
DE19735593C2 (de) * | 1997-08-15 | 1999-08-26 | Hepavec Ag Fuer Gentherapie | Hüllprotein-modifizierter Baculovirus-Vektor für die Gentherapie |
JP2003527816A (ja) * | 1998-07-24 | 2003-09-24 | アバンテイス・フアルマ・エス・アー | バキュロウイルス由来のベクター及び脊椎動物の神経細胞に核酸を導入するための該ベクターの使用 |
-
2000
- 2000-05-26 GB GBGB0012997.3A patent/GB0012997D0/en not_active Ceased
-
2001
- 2001-05-29 CN CN01810175A patent/CN1430675A/zh active Pending
- 2001-05-29 AU AU2001258657A patent/AU2001258657A1/en not_active Abandoned
- 2001-05-29 JP JP2001586586A patent/JP2003533992A/ja active Pending
- 2001-05-29 PL PL36028001A patent/PL360280A1/xx not_active Application Discontinuation
- 2001-05-29 HU HU0302119A patent/HUP0302119A3/hu unknown
- 2001-05-29 CA CA002413326A patent/CA2413326A1/en not_active Abandoned
- 2001-05-29 WO PCT/GB2001/002383 patent/WO2001090390A1/en not_active Application Discontinuation
- 2001-05-29 KR KR1020027015961A patent/KR20030072213A/ko not_active Application Discontinuation
- 2001-05-29 EP EP01931975A patent/EP1283894A1/en not_active Withdrawn
- 2001-05-29 IL IL15307001A patent/IL153070A0/xx unknown
- 2001-05-29 MX MXPA02011517A patent/MXPA02011517A/es unknown
-
2002
- 2002-11-25 NO NO20025657A patent/NO20025657D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2413326A1 (en) | 2001-11-29 |
IL153070A0 (en) | 2003-06-24 |
AU2001258657A1 (en) | 2001-12-03 |
HUP0302119A3 (en) | 2005-12-28 |
NO20025657L (no) | 2002-11-25 |
WO2001090390A1 (en) | 2001-11-29 |
JP2003533992A (ja) | 2003-11-18 |
CN1430675A (zh) | 2003-07-16 |
EP1283894A1 (en) | 2003-02-19 |
NO20025657D0 (no) | 2002-11-25 |
HUP0302119A2 (hu) | 2003-09-29 |
WO2001090390A9 (en) | 2003-01-09 |
GB0012997D0 (en) | 2000-07-19 |
PL360280A1 (en) | 2004-09-06 |
KR20030072213A (ko) | 2003-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011517A (es) | Uso de vectores de baculovirus en terapia genetica. | |
IL152549A0 (en) | Vectors for ocular transduction and use thereof for genetic therapy | |
AU2002367262A8 (en) | Personal user agent | |
AU7616001A (en) | Probiotic recolonisation therapy | |
GB0012671D0 (en) | Therapeutic agents | |
GB0004003D0 (en) | Therapeutic agents | |
GB0018473D0 (en) | Therapeutic agents | |
GB0017256D0 (en) | Therapeutic agents | |
GB0028429D0 (en) | Therapy | |
GB0005789D0 (en) | Therapeutic agents | |
GB0007907D0 (en) | Therapeutic agents | |
GB0012214D0 (en) | Therapeutic agents | |
GB0008696D0 (en) | Therapeutic agents | |
GB0000564D0 (en) | Therapeutic agents | |
GB0023610D0 (en) | Therapeutic agents | |
AU2002303261A8 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
GB0020721D0 (en) | Therapeutic agents | |
EP1164192A4 (en) | SORBITOL-DEHYDROGENASE, CODING GENE AND THE USE THEREOF | |
ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
GB0017543D0 (en) | Therapeutic agents | |
GB0008966D0 (en) | Vectors for gene therapy | |
EP1306432A4 (en) | HUMAN GENES OF THE 5-ALPHA REDUCTASE PROMOTOR OF TYPE II AND THEIR APPLICATIONS | |
GB0022988D0 (en) | Therapeutic agents | |
GB0014526D0 (en) | Massage/manipulation ball | |
GB0005846D0 (en) | Gene therapy |